Evaluation of immunogenicity and protective efficacy of a liposome containing Brucella abortus S19 outer membrane protein in BALB/c mice

Authors

  • A. Prasad Research & Development Laboratory, National Dairy Development Board, Gachibowli, Hyderabad 500032, Telangana, India;Department of Bio-Technology, Jawaharlal Nehru Technological University, Hyderabad 500032, Telangana, India
  • F. Mukherjee Research & Development Laboratory, National Dairy Development Board, Gachibowli, Hyderabad 500032, Telangana, India
  • G. K. Sharma Animal Health, National Dairy Development Board, Anand, 388001, Gujarat, India
  • L. Rajendra Research and Development, Santha Biotechnniques (AS Sanofi Company), Athivelly PlotNo. 4, Medchal, Ranga Reddy District, Hyderabad-501401, India
  • S. K. Rana Research & Development Laboratory, National Dairy Development Board, Gachibowli, Hyderabad 500032, Telangana, India
  • V. A. Srinivasan Animal Health, National Dairy Development Board, 33 Telecom Nagar, Gachibowli, Hyderabad 500032, Telangana, India
  • V. S. Bahekar Research & Development Laboratory, National Dairy Development Board, Gachibowli, Hyderabad 500032, Telangana, India
Abstract:

The use of liposome as an adjuvant and a vaccine carrier has been cited previously in the literature. It has also been shown to be effective in enhancing the immunogenicity of vaccine candidates. BALB/c mice immunized subcutaneously with outer membrane protein (OMP) of Brucella abortus S19 vaccine strain entrapped in a commercial cationic liposome (S19-OMP-liposome) for vaccine delivery, showed enhanced protection (P

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

evaluation of immunogenicity and protective efficacy of a liposome containing brucella abortus s19 outer membrane protein in balb/c mice

the use of liposome as an adjuvant and a vaccine carrier has been cited previously in the literature. it has also been shown to be effective in enhancing the immunogenicity of vaccine candidates. balb/c mice immunized subcutaneously with outer membrane protein (omp) of brucella abortus s19 vaccine strain entrapped in a commercial cationic liposome (s19-omp-liposome) for vaccine delivery, showed...

full text

Evaluation of immunogenicity and protective efficacy of a liposome containing Brucella abortus S19 outer membrane protein in BALB/c mice.

The use of liposome as an adjuvant and a vaccine carrier has been cited previously in the literature. It has also been shown to be effective in enhancing the immunogenicity of vaccine candidates. BALB/c mice immunized subcutaneously with outer membrane protein (OMP) of Brucella abortus S19 vaccine strain entrapped in a commercial cationic liposome (S19-OMP-liposome) for vaccine delivery, showed...

full text

Improved Immunogenicity of Tetanus Toxoid by Brucella abortus S19 LPS Adjuvant

Background: Adjuvants are used to increase the immunogenicity of new generation vaccines, especially those based on recombinant proteins. Despite immunostimulatory properties, the use of bacterial lipopolysaccharide (LPS) as an adjuvant has been hampered due to its toxicity and pyrogenicity. Brucella abortus LPS is less toxic and has no pyrogenic properties compared to LPS from other gram nega...

full text

ISOLATION AND PURIFICATION OF MAJOR OUTER MEMBRANE PROTEINS FROM BRUCELLA ABORTUS S-99

Isolation and purification of major outer membrane proteins (OMP) from the cell wall envelope of Brucella abortus S-99 were achieved by sonication, solubilization and membrane fractionation in the presence of non-ionic detergent (Tx-100) and lysozyme treatments, followed by ultracentrifugation. The crude OMP was treated with trypsin to free the preparation from any other protein contaminan...

full text

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice

Objective(s): Protection against leishmaniasis, in the murine model, is dependent on developing a potent CD4+ mediated Th1 type response. Liposomes can be applied as immunoadjuvants to stimulate immune responses to different antigens. In the present study, it was investigated whether DOTAP liposomes having SLA and imiquimod adjuvant, can induce a Th1 response and prote...

full text

Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.

BACKGROUND Adjuvants are used to increase the immunogenicity of new generation vaccines, especially those based on recombinant proteins. Despite immunostimulatory properties, the use of bacterial lipopolysaccharide (LPS) as an adjuvant has been hampered due to its toxicity and pyrogenicity. Brucella abortus LPS is less toxic and has no pyrogenic properties compared to LPS from other gram negati...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 17  issue 1

pages  1- 7

publication date 2016-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023